| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 02/07/2013 | US20130034592 Hydrogel |
| 02/07/2013 | US20130034591 Novel compounds and compositions for targeting cancer stem cells |
| 02/07/2013 | US20130034590 Delivery of Hydrophilic Drugs |
| 02/07/2013 | US20130034589 pH-SENSITIVE NANOPARTICLES FOR ORAL INSULIN DELIVERY |
| 02/07/2013 | US20130034504 Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity |
| 02/07/2013 | US20130034493 Methods and compositions for modulation of olfml3 mediated angiogenesis |
| 02/07/2013 | DE102011080389A1 Schutzfolienwechsler Protective film changer |
| 02/07/2013 | DE10084749B4 Substrat, welches mit einer Zusammensetzung behandelt ist, die einen botanischen Extrakt und ein Tensid enthält, sowie Körperpflegeartikel, welcher das behandelte Substrat enthält Substrate which is treated with a composition containing a botanical extract, and a surfactant, as well as personal care article comprising the treated substrate |
| 02/07/2013 | CA2852702A1 Thermally conductive, metal-based bandages to aid in medical healing and methods of use |
| 02/07/2013 | CA2844152A1 Stable anti-inflammatory solutions for injection |
| 02/07/2013 | CA2844008A1 Dissolution enhanced controlled drug delivery system for poorly water soluble drugs |
| 02/07/2013 | CA2843274A1 Synthetic nanocarriers that generate humoral and cytotoxic t lymphocyte (ctl) immune responses |
| 02/07/2013 | CA2843139A1 Corticosteroids for the treatment of joint pain |
| 02/07/2013 | CA2842802A1 Non-digestible capsules for the delivery of fluid absorbing materials |
| 02/07/2013 | CA2842577A1 Antiseptic composition |
| 02/07/2013 | CA2842276A1 Pharmaceutical composition of oxidised avidin suitable for inhalation |
| 02/07/2013 | CA2841644A1 Pharmaceutical composition comprising ebastine and fluticasone |
| 02/07/2013 | CA2841415A1 Pharmaceutical compositions comprising rifaximin, processes for their preparation and their use in the treatment of vaginal infections |
| 02/07/2013 | CA2839126A1 Tamper-resistant tablet providing immediate drug release |
| 02/07/2013 | CA2839123A1 Tamper-resistant tablet providing immediate drug release |
| 02/07/2013 | CA2839122A1 Intrathecal or epidural administration of 3-[(1s,2s)-3-(dimethylamino)-1-ethyl-2-methylpropyl]phenol |
| 02/06/2013 | EP2554185A1 Coating fat composition and particulate composition using same |
| 02/06/2013 | EP2554183A1 Pharmaceutical composition comprising a GLP-1-agonist, an insulin, and methionine |
| 02/06/2013 | EP2554179A1 Composition based on a vegetable extract for the treatment of cutaneous inflammatory forms, in particular psoriasis. |
| 02/06/2013 | EP2554169A1 Pharmaceutical preparation comprising phenylalanine derivative |
| 02/06/2013 | EP2554168A1 Controlled release pharmaceutical composition |
| 02/06/2013 | EP2554164A1 Pharmaceutical formulation based on ibuprofen and codeine having having improved stability |
| 02/06/2013 | EP2554161A1 Pharmaceutical composition comprising factor VII encapsulated in micelles |
| 02/06/2013 | EP2554160A1 Method for preparing an enriched IgG composition from plasma |
| 02/06/2013 | EP2554159A1 Dosage forms comprising apixaban and content uniformity enhancer |
| 02/06/2013 | EP2554042A1 Water-soluble iron supply agent with reducing power and with coffee grounds or tea dregs as raw material |
| 02/06/2013 | EP2553003A1 Melt-extruded film |
| 02/06/2013 | EP2553000A1 Supercritical fluid treatment of high molecular weight biopolymers |
| 02/06/2013 | EP2552969A1 Injectable drug delivery formulation |
| 02/06/2013 | EP2552487A1 Thermogelling anaesthetic compositions |
| 02/06/2013 | EP2552486A1 Transdermal delivery patch |
| 02/06/2013 | EP2552484A1 Methods and compositions for reducing parathyroid levels |
| 02/06/2013 | EP2552474A2 An insulin conjugate using an immunoglobulin fragment |
| 02/06/2013 | EP2552449A2 Improved methods and compositions for safe and effective treatment of erythema |
| 02/06/2013 | EP2552448A2 Improved methods and compositions for safe and effective treatment of telangiectasia |
| 02/06/2013 | EP2552447A1 Stable pharmaceutical composition of imatinib |
| 02/06/2013 | EP2552439A1 Methods of enhancing drug delivery and effectiveness of therapeutic agents |
| 02/06/2013 | EP2552438A1 Methods of treatment of hepatocellular carcinoma |
| 02/06/2013 | EP2552433A2 Compositions and methods for the treatment of somatosensory disorders |
| 02/06/2013 | EP2552426A2 Intravaginal drug delivery device |
| 02/06/2013 | EP2552425A1 Abuse-deterrent transdermal formulations of opiate agonists and agonist-antagonists |
| 02/06/2013 | EP2552424A1 Process for preparing carrier particles for dry powders for inhalation |
| 02/06/2013 | EP2552423A1 Stabilized formulations of cns compounds |
| 02/06/2013 | EP2552422A2 Long-acting interferon beta formulation using immunoglobulin fragment |
| 02/06/2013 | EP2552421A2 Long-acting human follicle-stimulating hormone formulation using immunoglobulin fragment |
| 02/06/2013 | EP2552420A1 Suspension and cake composition containing carbostyryl derivative and silicone oil and/or silicone oil derivative |
| 02/06/2013 | EP2552419A2 Modified release dosage form comprising desvenlafaxine or salts thereof |
| 02/06/2013 | EP2552418A2 A fast dissolving pharmaceutical composition |
| 02/06/2013 | EP2552417A2 Pharmaceutical formulations for the treatment of overactive bladder |
| 02/06/2013 | EP2552416A2 Compositions and methods for improved retention of a pharmaceutical composition at a local administration site |
| 02/06/2013 | EP2552415A1 Methods of treating cancer |
| 02/06/2013 | EP2552414A1 Pharmaceutical powder composition for inhalation |
| 02/06/2013 | EP2552413A2 Novel support system for the transport of active substances into the skin |
| 02/06/2013 | EP2552412A2 Emulsions for microencapsulation comprising biodegradable surface-active block copolymers as stabilizers |
| 02/06/2013 | EP2552411A2 Stabilized antibody preparations and uses thereof |
| 02/06/2013 | EP2552410A2 Method for preserving alum adjuvants and alum-adjuvanted vaccines |
| 02/06/2013 | EP2552409A1 Bioadhesive compositions of local anaesthetics |
| 02/06/2013 | EP2552408A2 Water-free pharmaceutical compositions suitable for local anaesthetics |
| 02/06/2013 | EP2552407A1 Composition comprising insulin and herbal oil for transdermal or transmucosal administration |
| 02/06/2013 | EP2552406A1 Photo-crosslinked gellan gum-based hydrogels: preparation methods and uses thereof |
| 02/06/2013 | EP2552405A2 Method for producing a drug delivery system on the basis of polyelectrolyte complexes |
| 02/06/2013 | EP2552404A1 Parenteral pharmaceutical form which releases aromatse inhibitor and gestagens, for the treatment of endometriosis |
| 02/06/2013 | EP2552403A2 A fast dissolving pharmaceutical composition |
| 02/06/2013 | EP2552402A2 Multilayer melt-extruded film |
| 02/06/2013 | EP2552392A2 Compositions |
| 02/06/2013 | EP2552234A1 Spray-dried crystalline active ingredient |
| 02/06/2013 | EP2552198A1 Antimicrobial wound dressing |
| 02/06/2013 | EP2552195A1 Antimicrobial oil-in-water emulsion |
| 02/06/2013 | CN1378445B Drug releasing biodegradable fiber implant |
| 02/06/2013 | CN102918086A Supercritical fluid treatment of high molecular weight biopolymers |
| 02/06/2013 | CN102917732A Immunoglobulin preparation and storage system for an immunoglobulin preparation |
| 02/06/2013 | CN102917722A Aqueous formulations for coating microneedle arrays |
| 02/06/2013 | CN102917712A Nail discoloration and fungus treatment |
| 02/06/2013 | CN102917697A Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances |
| 02/06/2013 | CN102917696A Aceclofenac slow-release preparation providing an optimum pharmacological clinical effect when administered once a day |
| 02/06/2013 | CN102917695A Atazanavir sulfate formulations with improved ph effect |
| 02/06/2013 | CN102917694A Tablet formulation of ezatiostat |
| 02/06/2013 | CN102917693A Implant devices that differe by release profile and methods of making and using same |
| 02/06/2013 | CN102917692A Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyriodin-2-yl)benzoic acid and administration thereof |
| 02/06/2013 | CN102917691A Process for making dry and stable hemostatic compositions |
| 02/06/2013 | CN102917690A Lipid vesicle compositions and methods of use |
| 02/06/2013 | CN102917689A Novel process |
| 02/06/2013 | CN102917688A Novel process |
| 02/06/2013 | CN102917687A Injectable emulsion of sedative hypnotic agent |
| 02/06/2013 | CN102911348A Polyester/polyethyleneglycol block copolymer containing hydroxyl pendant group and application of polyester/polyethyleneglycol block copolymer |
| 02/06/2013 | CN102911326A Acid-sensitive degradable polymer vesicle and preparation and application thereof |
| 02/06/2013 | CN102911279A Polysaccharide-peptide and liposome thereof |
| 02/06/2013 | CN102908707A Hui medicine oxygen mask and matched medical oxygen medicated pad as well as preparation method of medicated pad |
| 02/06/2013 | CN102908628A Cellulose rhodophyta polysaccharide film coating premix and solution preparation method thereof |
| 02/06/2013 | CN102908626A Method for preparing chitosan/ transparent acid derivative nanofiber composite film through freezing drying technology |
| 02/06/2013 | CN102908611A Bioprotein dressing and bioprotein invisible film for preventing and controlling human papilloma virus infection |
| 02/06/2013 | CN102908607A External traditional Chinese medicine for treating chronic simple rhinitis and preparation method thereof |
| 02/06/2013 | CN102908604A Bighead atractylodes rhizome and gastrodia tuer capsules |
| 02/06/2013 | CN102908601A Preparation method of huoxiang zhengqi pills |
| 02/06/2013 | CN102908600A Preparation method for ease pills |